Connect with us

One-Hit Wonders

Cannabis Foods In Greece: A Blurry Legal Framework

Published

on


Under Greek law, unprocessed products gathered from the cultivation of the Cannabis Sativa L plant which contain tetrahydrocannabinol (THC) at a concentration of less than 0,2%, are not considered to be illegal narcotic drugs. It is noted that in accordance with the new EU Common Agricultural Policy for 2023, it has been announced that this THC concentration level is intended to be increased to 0,3%.

However, the above THC level only concerns the unprocessed product gathered from the Cannabis plant, and not final products intended for consumption. Therefore, it does not mean that Cannabis-derived foods and food supplements containing THC under 0,2% are per se legal under the Greek framework.

In relation to the circulation of foodstuffs (with the exception of children’s foods), food supplements and cosmetics deriving from Cannabis Sativa L, Greek Law has provided that Ministerial Decisions shall be issued which will set the appropriate limits of THC concentration for each category of products, as well as the further requirements for the circulation of such products in the market.

On the one hand, regarding food supplements, a Ministerial Decision was published in June 2022 establishing that Cannabis supplements should not contain THC at a detectable level (i.e. the THC level should be less than 0.0001%). In addition, if the supplements contain ingredients that are “novel foods” (such as cannabidiol – CBD), the relevant authorization of the EU Novel Foods Regulation is first required.

On the other hand, regarding foodstuffs, even though a working group has been set-up at the Greek Ministry of Agriculture and Foods in order to proposethe appropriate THC limits in foods and to draft the necessary provisions that would regulate their legitimate circulation, the relevant Ministerial Decision has not yet been issued. Therefore, the issue of the legitimate circulation, marketing and advertising of “cannabis foods” currently remains a grey legal area.

In addition to the above, it is noted that cannabinoids, including cannabidiol (CBD), which do not have a history of consumption in the EU prior to 1997, fall under the category of “novel foods” and, therefore, their circulation needs first to be authorized according to the relevant EU Regulation 2283/2015. The competent authority regarding novel foods in Greece is the General Chemical Laboratory of the State. In relation to the issue of CBD as a novel food, the European Food Safety Authority (EFSA) published a statement in June 2022, indicating that the safety of CBD for human consumption as a food (not as medicine) cannot currently be established, and that more data will be needed in order to complete the assessment.

At the same time, some products deriving from certain edible natural parts of the Cannabis Sativa L plant, such as seeds, seed oil, seed flour, have been consumed in the EU prior to 1997 according to the EU novel food catalogue, and therefore are not subject to the Novel Foods Regulation (provided that they do not contain other ingredients that are “novel foods”, such as CBD). However, as mentioned above, relevant legal provisions are still expected to be issued in Greece in order to regulate the appropriate THC levels of such “cannabis foods”.

The current situation in the Greek market is that a number of Cannabis foodstuffs (and food supplements) are advertised online and are available for purchase in a growing number of e-shops and physical stores, most of which specialize in selling specifically this category of products.

Nevertheless, it follows from the above that there are still many grey areas regarding the legality of marketing and circulation of Cannabis foods in Greece, under the current, blurry, legal framework.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Source Mondaq

https://www.mondaq.com/unitedstates/cannabis–hemp/1289718/cannabis-foods-in-greece-a-blurry-legal-framework



Source link

Continue Reading

One-Hit Wonders

Driving Under the Influence of Marijuana

Published

on

By


No national standard exists to determine how long someone should wait to drive after consuming marijuana. However, experts at the Colorado Department of Public Health and Environment recommend waiting at least six hours after smoking less than 35 milligrams of THC and eight hours after eating or drinking something containing less than 18 milligrams.

For reference, a “typical” marijuana cigarette contains at least 60 milligrams of THC, and most edibles contain around 10 milligrams per serving size. A 12-hour wait is safer, as the high (and subsequent drowsiness) from smoking a typical amount lasts far longer.



Source link

Continue Reading

One-Hit Wonders

How can it help distressed cannabis companies today?

Published

on

By


Without the option to declare bankruptcy—due to federal illegality—the only recourse for cannabis businesses in distress to become solvent and / or distribute assets to creditors is to enter into an expensive and difficult judicial cannabis receivership. Receiverships are inherently adversarial, and the required input from third-party experts, lawyers and regular engagement with the courts can be incredibly costly.

Meanwhile, businesses operating in mainstream sectors have the ability to declare bankruptcy. This is also a court-ordered procedure that allows companies to satisfy lenders by liquidating assets, restructuring operations and finances, and to enjoy a break of sorts to make deals with creditors and renegotiate contracts and leases. Without a change to federal banking laws, cannabis companies are blocked from the benefits of bankruptcy, and the situation is only getting worse.

Given the current tight capital market environment, the increase in cannabis distressed assets, and the shortage of options to cannabis operators to address said challenges, is there a possible alternative option to alleviate the rather dire situation?

 

Genesis—Transition from Equity Financing to Debt Financing

Equity financing has been the most prominent way to raise capital in cannabis for the last several years. However,recent data collected by Viridian Capital Advisorsreveals that debt currently makes up 93% of capital raised by U.S. cannabis cultivation and retail companies, compared to 55.7% in U.S. industries overall.

This change in the capital-raising environment, which has led to an increased number of creditors in the sector, combined with continued market pressures on cannabis businesses to remain competitive, make it highly likely that the industry will inevitably see more receiverships.

Ultimately, while debt financiers are willing to lend cannabis businesses money, they expect to be paid back on time and often with high interest. If the business begins to struggle and enters a distressed phase that leads to receivership, the business assets will be sold off and the secured lenders will be the first to get paid, while the business itself is likely not to recover much.

Consider an Administrative and Collateral Agent

With receiverships punishingly expensive and the debt financing landscapebordering on predatorial, distressed cannabis businesses are desperate for any assistance or support available.  An Administrative and Collateral Agent (ACA) could be the alternative support required, benefitting borrowers, lenders and regulators alike, and offering a more cost-effective and less punitive option to courts, receivers and lawyers.

Instead of dealing with the courts and an expensive court-appointed receiver, cannabis companies seeking relief could turn to an ACA to facilitate mediation between parties and create alignment within the industry, which does not exist today.

An ACA could create a level of trust, transparency and complementary positioning with industry participants that simply has not yet existed in cannabis. The use of an ACA could challenge the competing perceptions that there is already alignment between regulators, operators and lenders, or that a useful alignment between these parties could ever exist.

An ACA could be a real and valuable tool for state governments and regulators as they begin to understand that it is in their best interests to assist cannabis businesses in their states in the face of continued federal illegality and restrictions. Under a private agreement between parties, the ACA would conduct something more akin to an administrative receivership as opposed to the traditional judicial receivership that is the only current option for insolvent cannabis businesses to seek relief.

Building upon a Cannabis Credit Rating Framework

Ideally, an ACA would work within an industry-specific credit rating system for cannabis businesses in distress in order to work within an established framework for potential investors. If cannabis companies are ranked across an equitable, systematic and formulaiccredit rating system, borrowers, lenders and regulators would benefit from the quantifiable transparency afforded by said rating, and debt financing would have an inherent regulatory-like structure to prevent predatory lending. By avoiding the courts, the distressed cannabis company would save time, money and create a more attractive scenario for potential lenders.

Initial Path to Mitigating Solutions

While the current challenges facing cannabis businesses today are well documented and have risen to both creditors and regulators attention, a viable solution has yet to be identified. Most likely no one solution exists beyond waiting for the economic and capital environments to evolve. Yet, mitigating options do exist.

The introduction of an ACA is one such option. Questions remain as to the mechanics, regulatory, operative and fiscal alike, as well as who to trust to take it on. The introduction of a credit rating framework is the first step to creating a solid foundation from within which an ACA can operate transparently and equitably. Any potential buy-in from regulators, creditors and operators remains an open question.

All of that said, there is today an unprecedented set of market forces that is pushing all cannabis stakeholders to think outside of the box. The still growing opportunities in the cannabis industry, the will of operators to survive and succeed, as well as the increasing exposure from creditors, all point to not only an acceptance for the need of an alternative, but to the drive to do things differently.

Is your cannabis business in distress? Would you benefit from expert guidance and support in deciding on whether to enter into a receivership?Reach out to United CMC today.



Source link

Continue Reading

One-Hit Wonders

United States: Alex Malyshev And Melinda Fellner Discuss The Intersection Of Tax And Cannabis In New Video Series – Part VI: Licensing (Video)

Published

on

By


Carter Ledyard is pleased to announce the launch of our short-video series on the cannabis industry focusing on business and legal issues for those companies and entities interested in doing business in New York.

This series offers a perspective on tax policy and specific statutes affecting cannabis businesses today. Our cannabis shorts are a great way to get to know our professionals, Alex Malyshev and Melinda Fellner, in quick and easy to watch clips, packed with the salient information you need.

In Part VI of our series, Alex and Melinda discuss licensing for cannabis businesses in New York. Watch below!

 



Source link

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media